Protagonist Therapeutics price target raised to $180 by Barclays
Barclays raised its price target on Protagonist Therapeutics to $180.00 per share from $153.00, according to Benzinga (via TradingView News).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.